Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC): Overview and Management

Primary Biliary Cholangitis (PBC) is a chronic, progressive autoimmune liver disease that leads to the gradual destruction of small bile ducts within the liver. It primarily affects women, with a female-to-male ratio of at least 9:1.

Key Features of PBC

Bile Duct Damage: PBC causes inflammation and scarring of the intrahepatic bile ducts, leading to bile buildup in the liver (cholestasis).
Progression: Without treatment, PBC can lead to liver fibrosis, cirrhosis, and eventually liver failure.
Prevalence: PBC is a relatively rare condition, affecting approximately 1 in 3,000 to 4,000 people.

Symptoms of PBC

Early Stages:

Many individuals are asymptomatic at the time of diagnosis, with about 60% identified before symptoms appear.

Common Early Symptoms:

Fatigue
Itchy skin (pruritus)
Upper right abdominal discomfort
Dry eyes and mouth (often associated with Sjögren’s syndrome)

Progressive Symptoms:

Jaundice (yellowing of the skin and eyes)
Darkened skin pigmentation
Xanthomas (yellow fatty deposits on the skin)
Osteoporosis (bone weakening)

Diagnosis of PBC

A diagnosis of PBC typically involves a combination of the following:

Blood Tests:

Liver function tests (LFTs) to assess bile buildup
Anti-Mitochondrial Antibodies (AMA), which are present in over 90% of PBC cases and serve as a key diagnostic marker

Imaging Studies:

Ultrasound, FibroScan, or MRI to evaluate liver health and rule out other conditions

Liver Biopsy:

Occasionally performed to confirm the diagnosis or assess disease severity

Treatment Options for PBC

Although there is no cure for PBC, treatment focuses on slowing disease progression and managing symptoms.

First-Line Treatment:

Ursodeoxycholic Acid (UDCA) is the primary medication used to improve bile flow and slow liver damage.

Second-Line Therapy:

Obeticholic Acid may be prescribed if UDCA alone is ineffective.

Symptom Management:

Medications such as cholestyramine can help manage itching (pruritus).
Fatigue management strategies may be recommended, though no specific medication is approved.
Calcium and vitamin D supplementation support bone health.

Liver Transplantation:

Considered for advanced liver failure or severe complications.

Prognosis & Long-Term Management

With early diagnosis and treatment, many individuals maintain a good quality of life. Regular monitoring of liver function and complications is essential. Lifestyle modifications, including a healthy diet, avoiding alcohol, and vitamin supplementation, can support liver health.

Conclusion:

PBC is a manageable condition with proper treatment and ongoing medical care. Working closely with a healthcare provider helps slow disease progression and improves long-term outcomes.

Primary Biliary Cholangitis (PBC)